Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice
about
A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.The potential role of ribosomal frameshifting in generating aberrant proteins implicated in neurodegenerative diseases.Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy.The Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting ProteinPABPN1: molecular function and muscle disease.Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway.Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.Interactions between homopolymeric amino acids (HPAAs).Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway.Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.RBPMetaDB: a comprehensive annotation of mouse RNA-Seq datasets with perturbations of RNA-binding proteins.Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuRA polyalanine antibody for the diagnosis of oculopharyngeal muscular dystrophy and polyalanine-related diseases
P2860
Q34518248-D076BE8D-BE85-46D3-B085-43682C6F6753Q34702915-7A799B9A-15CA-4E47-9EB6-915CE079C30BQ35577123-35C869EA-1581-4C92-AE9C-51775EF51234Q35790486-382AAD1F-6C60-4EC0-9A66-DAF26AF1787EQ38100286-5125531E-04CE-4F31-9175-035FFC7FE671Q39087896-43372476-8341-4843-8600-20C5EA447192Q39256785-B551E9A3-7A98-4920-8E1C-F6DD2B7E7483Q42081147-B38848EC-B751-48B2-A253-AD7AA4D731C6Q50962265-C42D738D-00E7-4236-AD76-1EFBCD967091Q53173112-0B21F0FC-0F83-402B-9563-725217AD840FQ54568812-B2E23AF6-5283-45B0-875B-C3C3B1B5C7AFQ55260756-DD91BEB8-A984-405D-87A1-FC9E8422D6B3Q57160226-155F318B-E83A-4818-8FF6-9398A46C6B5EQ57233128-E2ABC389-653A-44B8-8C44-96996111E4FA
P2860
Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Transgenic expression of an ex ...... d coordination defects in mice
@ast
Transgenic expression of an ex ...... d coordination defects in mice
@en
Transgenic expression of an ex ...... d coordination defects in mice
@nl
type
label
Transgenic expression of an ex ...... d coordination defects in mice
@ast
Transgenic expression of an ex ...... d coordination defects in mice
@en
Transgenic expression of an ex ...... d coordination defects in mice
@nl
prefLabel
Transgenic expression of an ex ...... d coordination defects in mice
@ast
Transgenic expression of an ex ...... d coordination defects in mice
@en
Transgenic expression of an ex ...... d coordination defects in mice
@nl
P2093
P50
P1476
Transgenic expression of an ex ...... d coordination defects in mice
@en
P2093
Carol Allen
Christiane Messaed
Claudia Gaspar
Daniel Rochefort
George Karpati
Inge Meijer
Janet Laganiere
Julie Roussel
Patrick Dion
Simon Laganiere
P304
P356
10.1016/J.NBD.2004.09.021
P407
P577
2005-04-01T00:00:00Z